197 related articles for article (PubMed ID: 16412099)
21. The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin.
Lee DK; Ferguson SS; George SR; O'Dowd BF
Biochem Biophys Res Commun; 2010 Apr; 395(2):185-9. PubMed ID: 20353754
[TBL] [Abstract][Full Text] [Related]
22. Visualization of agonist-induced association and trafficking of green fluorescent protein-tagged forms of both beta-arrestin-1 and the thyrotropin-releasing hormone receptor-1.
Groarke DA; Wilson S; Krasel C; Milligan G
J Biol Chem; 1999 Aug; 274(33):23263-9. PubMed ID: 10438501
[TBL] [Abstract][Full Text] [Related]
23. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2003 Apr; 278(16):14498-506. PubMed ID: 12574160
[TBL] [Abstract][Full Text] [Related]
24. A phosphorylation-regulated brake mechanism controls the initial endocytosis of opioid receptors but is not required for post-endocytic sorting to lysosomes.
Whistler JL; Tsao P; von Zastrow M
J Biol Chem; 2001 Sep; 276(36):34331-8. PubMed ID: 11443128
[TBL] [Abstract][Full Text] [Related]
25. Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking.
Mundell SJ; Matharu AL; Kelly E; Benovic JL
Biochemistry; 2000 Oct; 39(42):12828-36. PubMed ID: 11041847
[TBL] [Abstract][Full Text] [Related]
26. Glucagon receptor recycling: role of carboxyl terminus, beta-arrestins, and cytoskeleton.
Krilov L; Nguyen A; Miyazaki T; Unson CG; Bouscarel B
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1230-7. PubMed ID: 18787074
[TBL] [Abstract][Full Text] [Related]
27. Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice.
Fong AM; Premont RT; Richardson RM; Yu YR; Lefkowitz RJ; Patel DD
Proc Natl Acad Sci U S A; 2002 May; 99(11):7478-83. PubMed ID: 12032308
[TBL] [Abstract][Full Text] [Related]
28. Identification of distinct c-terminal domains of the Bombyx adipokinetic hormone receptor that are essential for receptor export, phosphorylation and internalization.
Huang H; Deng X; He X; Yang W; Li G; Shi Y; Shi L; Mei L; Gao J; Zhou N
Cell Signal; 2011 Sep; 23(9):1455-65. PubMed ID: 21536126
[TBL] [Abstract][Full Text] [Related]
29. Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor.
Holliday ND; Holst B; Rodionova EA; Schwartz TW; Cox HM
Mol Endocrinol; 2007 Dec; 21(12):3100-12. PubMed ID: 17717076
[TBL] [Abstract][Full Text] [Related]
30. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
[TBL] [Abstract][Full Text] [Related]
31. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy.
Ferrari SL; Behar V; Chorev M; Rosenblatt M; Bisello A
J Biol Chem; 1999 Oct; 274(42):29968-75. PubMed ID: 10514480
[TBL] [Abstract][Full Text] [Related]
32. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
Fessart D; Simaan M; Laporte SA
Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone receptor recycling: role of receptor dephosphorylation and beta-arrestin.
Chauvin S; Bencsik M; Bambino T; Nissenson RA
Mol Endocrinol; 2002 Dec; 16(12):2720-32. PubMed ID: 12456793
[TBL] [Abstract][Full Text] [Related]
34. Heterologous inhibition of G protein-coupled receptor endocytosis mediated by receptor-specific trafficking of beta-arrestins.
Klein U; Müller C; Chu P; Birnbaumer M; von Zastrow M
J Biol Chem; 2001 May; 276(20):17442-7. PubMed ID: 11278476
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the fate of type I angiotensin receptor after biased activation.
Szakadáti G; Tóth AD; Oláh I; Erdélyi LS; Balla T; Várnai P; Hunyady L; Balla A
Mol Pharmacol; 2015 Jun; 87(6):972-81. PubMed ID: 25804845
[TBL] [Abstract][Full Text] [Related]
36. Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes.
Ismail S; Gherardi MJ; Froese A; Zanoun M; Gigoux V; Clerc P; Gaits-Iacovoni F; Steyaert J; Nikolaev VO; Fourmy D
Biochem Pharmacol; 2016 Nov; 120():33-45. PubMed ID: 27641811
[TBL] [Abstract][Full Text] [Related]
37. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis.
Smith J; Yu R; Hinkle PM
Mol Endocrinol; 2001 Sep; 15(9):1539-48. PubMed ID: 11518803
[TBL] [Abstract][Full Text] [Related]
38. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2005 Apr; 280(15):15315-24. PubMed ID: 15699045
[TBL] [Abstract][Full Text] [Related]
39. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation.
Cui W; Simaan M; Laporte S; Lodge R; Cianflone K
Mol Immunol; 2009 Sep; 46(15):3086-98. PubMed ID: 19615750
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of G protein-coupled receptor desensitization and resensitization.
Ferguson SS; Zhang J; Barak LS; Caron MG
Life Sci; 1998; 62(17-18):1561-5. PubMed ID: 9585136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
